Organon & Co. (OGN)

Pharmaceuticals

OGN · NEW YORK STOCK EXCHANGE, INC. · USD

New to investing? How to read this page →

$13.53

+0.22%

Watch Compare

Price · 1 year

Watch + Add to portfolio

Loading live analysis…

Loading analysis…

Intrinsic Investor is for education and research only — not financial advice.

Key metrics

EPS

$0.72

ROE

34.0%

Gross margin

53.8%

Debt/Equity

9.49x

Revenue growth

-3.5%

Organon & Co. — company intelligence

Earnings surprises

Q1 2026$0.71 vs $0.84 est-15.2%

Q4 2025$0.63 vs $0.73 est-14.2%

Q3 2025$1.01 vs $0.95 est+6.8%

Q2 2025$1.00 vs $0.96 est+4.5%

Insider activity · 90 days

9 buys1 sellnet +134,265 shares

Sharp ShaliniBuy 17,857 · Jun 12, 2026

Ezekowitz AlanBuy 17,857 · Jun 12, 2026

Gayle Helene DBuy 17,857 · Jun 12, 2026

Recent SEC filings

4 — Insider transaction reportJun 15, 2026

Latest news

Organon To Present Phase 3 Data Of VTAMA Cream In Atopic Dermatitis At 2026 Society For Pediatric Dermatology Annual Meeting — Benzinga · 4d ago

Organon And Samsung Bioepis Expand Their Development And Commercialization Agreement To Provide OGN With Commercialization Rights In Canada To PYZCHIVA, Samsung Bioepis's Biosimilar Referencing STELARA — Benzinga · 3w ago

Organon & Co. (OGN) Shareholder/Analyst Call - Slideshow — SeekingAlpha · 3w ago

Organon's Supplemental Biologics License Application Gets FDA Approval For TOFIDENCE To Treat Chimeric Antigen Receptor T Cell-Induced Severe Or Life-Threatening Cytokine Release Syndrome — Benzinga · Jun 10, 2026

AI Valuation Narrative

Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.

Screen Stocks Learn Intrinsic Value Trading Signals Compare Stocks

Explore more

More in Pharmaceuticals →More in Drug Manufacturers - General →Stocks in US →Stocks on NEW YORK STOCK EXCHANGE, INC. →Compare stocks side-by-side →

Peers & similar stocks

Quick links to related tickers for research.

Novo Nordisk A/SNVO Eli Lilly and CoLLY Johnson & JohnsonJNJ Merck & Co IncMRK AstraZeneca PLCAZN Pfizer, Inc.PFE

About Organon & Co.

Weekly undervalued picks (like OGN)

Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.

Free. No spam. We only email once per week.

Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.